phenylbutazone has been researched along with Diabetes Mellitus, Adult-Onset in 3 studies
Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Sharma, A | 1 |
Pagidipati, NJ | 1 |
Califf, RM | 1 |
McGuire, DK | 1 |
Green, JB | 1 |
Demets, D | 1 |
George, JT | 1 |
Gerstein, HC | 1 |
Hobbs, T | 1 |
Holman, RR | 1 |
Lawson, FC | 1 |
Leiter, LA | 1 |
Pfeffer, MA | 1 |
Reusch, J | 1 |
Riesmeyer, JS | 1 |
Roe, MT | 1 |
Rosenberg, Y | 1 |
Temple, R | 1 |
Wiviott, S | 1 |
McMurray, J | 1 |
Granger, C | 1 |
Shah, SJ | 1 |
Bhandarkar, SD | 1 |
Satoskar, RS | 1 |
Speders, S | 1 |
3 other studies available for phenylbutazone and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; | 2020 |
Drug interaction between chlorpropamide and non-steroidal anti-inflammatory drugs, ibuprofen and phenylbutazone.
Topics: Adult; Aged; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Interactions; Humans; Ib | 1984 |
[Mofebutazone--evaluation of possible interaction with glibenclamide].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Blood Glucose; Diabetes Mellit | 1993 |